Description
An agonist of GPR55 (EC50 = 2.5 µM in a GTPγS binding assay); selective for GPR55 over CB1 and CB2 (EC50s = >30 µM for both in GTPγS binding assays); a full agonist at GPR18 (EC50 = 0.835 µM for inducing p44/42 MAPK phosphorylation in HEK293 cells expressing GPR18); increases migration of BV-2 microglial cells (EC50 = 0.6 µM); decreases blood pressure in anesthetized rats at 20 µg/g, i.v. or at 0.4 and 0.8 µg via rostral ventrolateral medulla injection
Formal name: 4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol
Synonyms: Abn-CBD
Molecular weight: 314.5
CAS: 22972-55-0
Purity: ≥98%
Formulation: A solution in methyl acetate
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors